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Disorders of the extrahepatic bile duct carry considerable morbidity 
and mortality. Indeed, 70% of pediatric liver transplantations are per-
formed to treat biliary atresia1, while primary sclerosing cholangitis 
(PSC) alone accounts for 5% of liver transplantations in the United 
States2 and biliary complications are the leading cause of graft failure 
following deceased donor liver transplantation3,4. Treatment options 
remain limited5,6 owing to the lack of healthy donor tissue that can 
be used to reconstruct and replace diseased bile ducts. In vitro expan-
sion of native cholangiocytes could address this limitation and pro-
vide cells suitable for tissue engineering applications such as biliary 
reconstruction. However, the culture of primary biliary epithelium 
remains problematic7. Here we report a new method, compatible with 
regenerative medicine applications, for the isolation and propagation 
of primary human cholangiocytes from the extrahepatic biliary tree. 
The resulting ECOs express key biliary markers, such as cytokera-
tin 7 (KRT7 or CK7), cytokeratin 19 (KRT19 or CK19), γ-glutamyl 
transferase (GGT) and cystic fibrosis transmembrane conductance 
regulator (CFTR), and maintain their functional properties in vitro, 
including alkaline phosphatase (ALP) and GGT activity and responses 
to secretin and somatostatin. The potential of ECOs in tissue engi-
neering and clinical applications is further illustrated by their capac-
ity to populate biodegradable scaffolds, organize into a functional 
biliary epithelium and rescue a mouse model of extrahepatic biliary 
injury (EHBI).
RESULTS
Human extrahepatic cholangiocytes can be propagated as organoids
We first focused on identifying the optimal conditions under which 
to isolate primary cholangiocytes from the biliary epithelium, 
which forms a monolayer covering the luminal surface of the bil-
iary tree8. We tested several approaches for recovering these cells 
(Supplementary Fig. 1a–c); mechanical dissociation by brushing or 
scraping the bile duct luminal surface was associated with improved 
survival of the cholangiocytes as compared to enzymatic digestion 
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of the bile duct (Fig. 1a and Supplementary Fig. 1a). Furthermore, 
the majority of the cells resulting from mechanical dissociation 
coexpressed the biliary markers CK7 and CK19 (94.6% ± 2.4%, s.d.; 
n = 3 independent dissociation experiments), and no contamina-
tion from mesenchymal cell types was detected (Supplementary 
Fig. 1d). Consequently, mechanical dissociation constitutes the opti-
mal method for isolating extrahepatic cholangiocytes.
To discern appropriate conditions for the maintenance and propa-
gation of these cells, we optimized our recently established system 
for 3D culture of intrahepatic cholangiocytes derived from human 
induced pluripotent stem cells9,10. Screening of multiple growth 
factors known to support the expansion of both cholangiocytes 
and epithelial organoids11,12 (Supplementary Fig. 1b,c) identified 
the combination of epidermal growth factor (EGF), R-spondin and 
Dickkopf-related protein 1 (DKK-1) as sufficient to promote the 
growth of primary cholangiocytes into organoids (Supplementary 
Fig. 1c). Because of the paradoxical requirement for both a Wnt 
potentiator (R-spondin) and a Wnt inhibitor (DKK-1), we charac-
terized the activity of both the canonical and noncanonical (planar 
cell polarity, PCP) Wnt pathways in ECOs. Our results demonstrate 
higher β-catenin phosphorylation in ECOs than in cells treated with 
R-spondin but not DKK-1 (Supplementary Fig. 1e,f), signifying 
lower canonical Wnt pathway activity in these cells. Furthermore, 
ECOs exhibited higher Rho kinase activity than cells treated with 
R-spondin but not DKK-1 (Supplementary Fig. 1g), which could be 
consistent with enhanced signaling through the noncanonical PCP 
pathway in ECOs. Thus, it is possible that noncanonical Wnt signaling 
controls ECO expansion, marking a notable difference with previous 
organoid culture conditions12.
Under these conditions, we derived eight different ECO lines 
(Fig. 1a–d, Supplementary Figs. 2a–f and 3a–e, and Supplementary 
Table 1) from a variety of deceased donors aged 33–77 years. Notably, 
we obtained similar results by using cholangiocytes isolated from the 
gallbladder or by isolating CBD cholangiocytes using an endoscopic 
retrograde cholangiopancreatography (ERCP) brush instead of scrap-
ing the luminal surface (Supplementary Fig. 2a,b). Consequently, 
ECOs can be derived from different areas of the extrahepatic biliary 
tree and collected using perioperative (dissection and scraping) or 
minimally invasive (ERCP brushing) approaches.
ECOs maintain expression of key biliary markers and functional 
properties in culture
The resulting cells were expanded in vitro for prolonged periods 
of time (Supplementary Fig. 4a), during which they maintained 
their genetic stability (Supplementary Fig. 4b,c). Electron micros-
copy revealed the presence of ultrastructural features characteristic 
of cholangiocytes, including cilia, microvilli and tight junctions13 
(Supplementary Fig. 3c), while qRT–PCR and immunofluorescence 
(IF) analyses established the expression of key biliary markers, includ-
ing KRT7, KRT19, hepatocyte nuclear factor-1β (HNF-1β), GGT, 
secretin receptor (SCTR), sodium-dependent bile acid transporter 
(SLC10A2; also known as ASBT), CFTR and SRY-box 9 (SOX9)9  
(Fig. 1b,c and Supplementary Figs. 2c,d and 3d,e). Of note, expres-
sion was not detected for stem cell markers, such as OCT4 (POU5F1), 
NANOG, prominin 1 (PROM1) and leucine-rich-repeat-containing 
G-protein-coupled receptors (LGR family: LGR4, LGR5 and LGR6); 
for markers of non-biliary lineages, including albumin (ALB), 
α1-antitrypsin (A1AT; also known as SERPINA1), keratin 18 
(KRT18), pancreatic and duodenal homeobox-1 (PDX1), insulin 
(INS) and glucagon (GCG); or for epithelial–mesenchymal transition 
(EMT) markers, such as vimentin (VIM), snail family transcriptional 
repressor 1 (SNAI1) and S100 calcium-binding protein A4 (S100A4) 
(Supplementary Fig. 5a–c). On the other hand, 98.1% ± 0.9% (s.d.) 
of the cells (n = 3 cell lines) coexpressed CK7 and CK19 following 20 
passages in culture (Supplementary Fig. 1d), thereby confirming the 
presence of a nearly homogeneous population of cholangiocytes.
Transcriptomic analyses (Fig. 1d, Supplementary Fig. 6 and 
Supplementary Table 2) revealed that ECOs maintained a stable gene 
expression profile over multiple passages (Pearson correlation coef-
ficient for passage 1 versus passage 20 ECOs, r = 0.99; Supplementary 
Fig. 6a,b), expressed key biliary markers (Supplementary Fig. 6c) and 
clustered closely to freshly isolated cholangiocytes (Supplementary 
Fig. 6d) (Pearson correlation coefficient for primary cholangiocytes 
versus passage 20 ECOs, r = 0.92; Supplementary Fig. 6b). Gene 
ontology (GO) analyses confirmed enrichment of pathways that are 
typically activated in the biliary epithelium (Supplementary Fig. 6e). 
When considered collectively, these results demonstrate that primary 
cholangiocytes derived from the extrahepatic biliary tree can be 
expanded in vitro without losing their original characteristics.
We then further characterized ECOs by focusing on their func-
tion following long-term culture (20 passages). Biliary epithelium 
regulates the homeostasis of bile through transport of ions, water 
and bile acids8,14. The secretory capacity of ECOs was interrogated 
using rhodamine 123, a fluorescent substrate for the cholangiocyte 
surface glycoprotein multidrug resistance protein-1 (MDR1)15,16 
(Fig. 2a–c). Rhodamine 123 accumulated in the ECO lumen only in 
the absence of the MDR1 antagonist verapamil, thereby confirming 
active secretion through MDR1 (Fig. 2a–c). Luminal extrusion of bile 
acids17 was also demonstrated by showing that the fluorescent bile 
acid cholyl-lysyl-fluorescein (CLF) was actively exported from ECOs 
(Fig. 2d–f). Furthermore, ALP and GGT activities in ECOs were com-
parable to those in freshly plated primary cholangiocytes (Fig. 2g,h 
and Supplementary Fig. 2e,f). The response of ECOs to secretin and 
somatostatin was also assessed. Secretin promotes water secretion, 
resulting in distension of the bile duct lumen, whereas somatostatin 
negates the effects of secretin18–20. Accordingly, organoids exposed 
to secretin increased their diameter as compared to untreated con-
trols, whereas somatostatin inhibited the effect of secretin (Fig. 2i,j). 
Our data therefore demonstrate that ECOs maintain their functional 
properties after long-term culture.
ECOs self-organize into bile duct–like tubes after transplantation
These results prompted us to investigate the potential of ECOs for 
in vivo use, especially in regenerative medicine applications. We 
first characterized the potential of ECOs to engraft and survive in 
vivo by transplanting cells under the kidney capsule of NOD.Cg-
PrkdcscidIl2rgtm1Wjl (NSG) mice (Supplementary Fig. 7a) and main-
taining the mice for 12 weeks21. ECOs were successfully engrafted, 
forming tubular structures expressing biliary markers such as CK19 
(Supplementary Fig. 7b–d).
Notably, no tumor formation or expression of markers for differ-
entiation into other lineages was detected (Supplementary Fig. 7d). 
Thus, ECOs appear to maintain their basic characteristics even after 
prolonged engraftment in vivo under the kidney capsule.
ECO-populated scaffolds reconstruct the gallbladder wall
To assess the potential of ECOs for tissue engineering, we first inter-
rogated their capacity to populate biodegradable polyglycolic acid 
(PGA) scaffolds, which are commonly used to provide the struc-
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Figure 1 Derivation and characterization of ECOs. (a) Schematic representation of the method used for the derivation of ECOs. (b) qRT–PCR confirming 
the expression of biliary markers in ECOs after passage 1 (P1), passage 10 (P10) and passage 20 (P20) as compared to freshly isolated primary 
cholangiocytes (PC) and embryonic stem cells (ES) used as a negative control; n = 4 ECO lines. Center line, median; box, interquartile range (IQR); 
whiskers, range (minimum to maximum). Values are relative to those for the housekeeping gene HMBS, encoding hydroxymethylbilane synthase.  
(c) IF analyses confirming the expression of biliary markers by ECOs. Scale bars, 100 µm. Single-channel and higher-magnification images are  
provided in Supplementary Figure 3. (d) Euclidean hierarchical clustering analysis comparing the transcriptomes of primary cholangiocytes (Primary), 
passage 20 ECOs (ECO), human iPSC-derived intrahepatic cholangiocyte-like cells (iChoLC), embryonic stem cells (ES) and hepatocytes (HEP).  
For each probe, standard scores (z scores) indicate differential expression, measured as the number of s.d. from the average expression level across all 
the samples. Clusters of genes expressed in ECOs, primary cholangiocytes or both cell types (common) are indicated. GO analyses for each cluster  
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Indeed, PGA is one of the most widely used synthetic polymers 
because it does not induce inflammatory responses in surround-
ing tissue, is biodegradable, and is more flexible and easier to proc-
ess than natural polymers such as collagen23. To facilitate tracking of 
cells, ECOs expressing GFP were generated through viral transduc-
tion (Supplementary Fig. 8). The resulting GFP+ ECOs were seeded 
on PGA scaffolds where they attached to the PGA fibers within 
24–48 h and continued to grow for 4 weeks until they reached con-
fluency (Fig. 3a–d). Of note, primary cholangiocytes grown under 
2D conditions demonstrated limited expansion potential and failed 
to reach confluency when seeded on the scaffolds (Supplementary 
Fig. 9), suggesting that the proliferative capacity of ECOs is crucial for 
successful scaffold colonization. The populated PGA scaffolds 
(Fig. 3b,c) could easily be handled with forceps and divided into smaller 
pieces with a surgical blade. Furthermore, the cells populating the scaf-
folds retained expression of biliary markers such as CK7 and CK19 
(Fig. 3e,f), demonstrated no evidence of EMT (Fig. 3e,g) and main-
tained their functional properties, including ALP and GGT activity 
(Fig. 3h,i). Therefore, ECOs can populate PGA scaffolds while main-
taining their functionality and marker expression, thereby providing 
a bioengineered tissue resembling the biliary epithelium.
We then determined the capacity of ECOs to repair the biliary 
epithelium. To do so, we developed a mouse model of EHBI. More 
specifically, to simulate wall defects in the biliary tree requiring 
biliary reconstruction24, the biliary trees of healthy NSG mice 
were compromised by longitudinal incision of the gallbladder wall 
(Fig. 4a). The surgical defect in the gallbladder wall was subse-
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Figure 2 Functional characterization of ECOs. (a) Fluorescence images demonstrating secretion of fluorescent rhodamine 123, the substrate of MDR1, 
into the lumen of ECOs; secretion is inhibited by the MDR1 inhibitor verapamil. Scale bars, 100 µm. (b) Graphs depicting the fluorescence intensity along 
the white lines in the images in a. (c) Mean intraluminal fluorescence intensity normalized to background levels for freshly plated primary cholangiocytes 
(Rho PC), passage 20 ECOs (Rho P20) and passage 20 ECOs treated with verapamil (Ver). Error bars, s.d.; n = 1,565 measurements in total. ****P 
< 0.001, Kruskal–Wallis test with Dunn’s correction for multiple comparisons. (d) Luminal extrusion of the fluorescent bile acid CLF as compared to 
controls loaded with FITC, confirming bile acid transfer. Scale bars, 100 µm. (e) Graphs depicting the fluorescence intensity along the white lines in the 
images in d. (f) Mean difference between intra- and extraluminal fluorescence intensity for control ECOs loaded with FITC (FITC), primary cholangiocytes 
loaded with CLF (CLF PC) and passage 20 ECOs loaded with CLF (CLF P20); n = 1,947 total measurements. Error bars, s.d.; ****P < 0.001, Kruskal–
Wallis test with Dunn’s correction for multiple comparisons. (g) Staining of ECOs and primary cholangiocytes for ALP activity. Scale bars, 500 µm (left) 
and 1 cm (right). (h) Mean GGT activity in passage 20 ECOs versus primary cholangiocytes. Error bars, s.d.; n = 3 cell lines; ****P < 0.001, one-way 
ANOVA with Dunnett’s correction for multiple comparisons. (i,j) Mean diameter measurements (i) and live images (j) of ECOs treated with secretin or 
with secretin and somatostatin, demonstrating an increase in diameter following treatment with secretin. Error bars, s.d.; n = 8 organoids measured per 
condition; ***P < 0.001, #P > 0.05, Kruskal–Wallis test with Dunn’s correction for multiple comparisons. Diameter measurements in micrometers are 
indicated on each image. Merged images show the diameter of the same organoid before (left) and after (right) the treatment indicated in the column. 
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GFP-expressing ECOs into the injured animals (Fig. 4a–g and 
Supplementary Fig. 10a–f). Acellular PGA scaffolds and scaffolds 
populated with GFP-expressing fibroblasts (Supplementary Fig. 
11a–d) were used as negative controls. Mice receiving acellular scaf-
folds died within 24 h of the operation (Fig. 4b), and post-mortem 
examination of these animals revealed yellow pigmentation of the 
peritoneal cavity and seminal vesicles, which is consistent with bile 
leak (Supplementary Fig. 10a); all animals in the group receiving 
fibroblast-populated scaffolds failed to reconstruct the gallblad-
der, which was replaced by fibrotic tissue incompatible with bile 
transport or storage (Supplementary Fig. 11e–g). In contrast, ani-
mals transplanted with ECO-populated scaffolds survived for up to 
104 d without complications and were culled electively (Fig. 4b). 
Notably, the reconstructed gallbladders in the group transplanted 
with ECO-populated scaffolds were fully remodeled, with morphol-
ogy resembling that of their native (untransplanted) counterparts 
(Fig. 4c and Supplementary Fig. 10b). Histology (Fig. 4d), IF and 
qRT–PCR analyses of the ECO-reconstructed gallbladders (Fig. 4e 
and Supplementary Fig. 10c,d) demonstrated integration of GFP+ 
ECOs expressing biliary markers such as KRT19, KRT7, HNF-1β, 
SOX9, CFTR and a human-specific epitope for Ku80 (Fig. 4e and 
Supplementary Fig. 10c). Of note, the IF analyses also showed the 
presence of mouse mesenchymal cells expressing vimentin and 
endothelial cells expressing CD31 in the reconstructed biliary epi-
thelium, suggesting that the scaffold is colonized by endogenous 
cells after transplantation (Supplementary Fig. 10c). Furthermore, 
we also identified a population of GFP+vimentin+CK19− cells, sug-
gesting that ECOs may also contribute to the scaffold stroma in vivo, 
possibly through EMT (Supplementary Fig. 10c,e). The integrity of 
the reconstructed gallbladder lumen and its exposure to bile through 
continuity with the biliary tree were demonstrated using magnetic 




































































































Figure 3 ECOs dissociated to single cells can populate biodegradable PGA scaffolds. (a,b) Photographs of a PGA scaffold before (a) and  
after (b) treatment with ECOs. Scale bars, 1 cm. Images are representative of three different scaffolds. (c) Light microscopy images of a PGA scaffold 
populated with ECOs dissociated to single cells. Red arrowheads, fully populated scaffold; black arrowheads, cells recruiting new PGA fibers; white 
arrowheads, PGA fibers. Scale bars, 100 µm. (d) Confocal microscopy images demonstrating cell expansion at different time points after seeding of 
single GFP+ ECO cells on a PGA scaffold. White lines indicate the positions of the PGA fibers. Scale bars, 100 µm. (e) IF demonstrating expression of 
biliary markers and lack of expression of EMT markers by dissociated ECO cells seeded on PGA scaffolds. Scale bars, 100 µm. (f) qRT–PCR analyses 
demonstrating expression of biliary markers by ECOs before (ECOs) and after (scaffold) seeding on PGA scaffolds; n = 4 ECO lines. Center line, median; 
box, IQR; whiskers, range (minimum to maximum). Values are shown relative to those for the housekeeping gene HMBS. (g) Mean ratio of the numbers 
of CK7+ and CK19+ cells and CK19+ and vimentin (VIM)+ cells in IF analyses similar to the image shown in e. Error bars, s.d.; n = 6 cell lines;  
**P < 0.01, Mann–Whitney test. (h) Mean GGT activity of dissociated ECO cells populating a PGA scaffold. Error bars, s.d.; n = 4 scaffolds;  
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Number of mice at risk
Days 0 1 17 22 75 104
Control 2 2 0 0 0 0











































































































Biliary reconstruction Reconstructed gallbladder
Figure 4 Biliary reconstruction in a mouse model of EHBI using ECOs. (a) Schematic representation of the method used for biliary reconstruction.  
(b) Kaplan–Meier survival analysis demonstrating rescue of mice with EHBI following biliary reconstruction with ECO-populated scaffolds. **P < 0.01,  
log-rank test. (c) Images of gallbladders reconstructed with acellular PGA scaffold (scaffold only) or PGA scaffold populated with ECOs (transplanted) 
and native, non-reconstructed gallbladder control (not transplanted); gallbladders transplanted with ECO-populated scaffolds showed full reconstruction.  
CD, cystic duct; CBD, common bile duct; CHD, common hepatic duct; F, fundus; A, anterior surface; P, posterior surface. Scale bars, 500 µm. (d) H&E  
staining of a reconstructed gallbladder. L, lumen. Scale bar, 100 µm. (e) IF analyses demonstrating the presence of GFP+ ECOs expressing biliary markers  
in reconstructed gallbladder. Scale bars, 100 µm. Higher-magnification images are provided in Supplementary Figure 12. (f,g) FITC cholangiogram  
(n = 1) (f) and MRCP images (n = 2) (g) of reconstructed (transplanted) versus native control (not transplanted) gallbladders (GB); the reconstructed 
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surgery. The internal diameter of the mouse CBD is approximately 
100 µm and the wall thickness is <50 µm; these dimensions precluded 
the use of a PGA scaffold owing to mechanical properties. Instead, 
we generated tubular scaffolds of densified collagen (Fig. 5a,b) that 
were populated with GFP-expressing ECOs (Fig. 5c–e). The use of 
densified collagen enabled the generation of constructs with an exter-
nal diameter ranging from 250–600 µm and adequate strength to 
maintain a patent lumen (Fig. 5d). Notably, the cells populating the 
collagen scaffolds maintained expression of biliary markers such as 
KRT19, KRT7, HNF-1β, SOX9 and CFTR (Fig. 5f,g) and exhibited 
GGT and ALP enzymatic activity (Fig. 5h,i). Primary epithelial cells 
of a different origin (human mammary epithelial cells, HMECs) failed 
to survive and adequately populate densified collagen tubes under 
the same conditions (Supplementary Fig. 12a). Moreover, plated 
HMECs failed to survive in a 10% bile solution (Supplementary Fig. 
12b), further confirming the unique capacity of ECOs in generat-
ing bile-resistant bioengineered bile ducts. Collectively, these results 
demonstrate the capacity of ECOs to populate tubular densified col-
lagen scaffolds without losing their original characteristics.
We then explored the possibility of replacing the native CBD of 
NGS mice with a bioengineered duct consisting of an ECO-populated 
removal of the organ and were further confirmed with fluorescein 
isothiocyanate (FITC) cholangiograms (Fig. 4f,g, Supplementary 
Fig. 10f and Supplementary Video 1). Post-mortem surgical exami-
nation and full-body magnetic resonance imaging performed 104 d 
following transplantation showed no evidence of tumor formation 
(Supplementary Fig. 10f and Supplementary Video 2), and IF analy-
ses showed no GFP+ cells in adjacent liver tissue (data not shown). In 
contrast, control gallbladders reconstituted with fibroblast exhibited 
obliteration of the gallbladder lumen (Supplementary Fig. 11h,i) 
and replacement of the lumen and biliary epithelium by fibroblasts 
expressing the fibroblast-specific antigen S100A4 (Supplementary 
Fig. 11i,j). When considered collectively, our findings demonstrate 
the capacity of ECOs to colonize their physiological niche and regen-
erate part of the biliary tree without any complications.
Bioengineered bile ducts replace the native mouse bile duct 
Reconstruction of the gallbladder wall provided proof of principle 
for the capacity of ECOs to repair the biliary epithelium after injury; 
however, in the majority of extrahepatic bile duct disorders, the CBD 
is affected. Therefore, we focused on the generation of a tubular 












































































































Figure 5 ECOs can populate tubular densified collagen scaffolds. (a) Schematic representation of the method used to generate tubular densified 
collagen scaffolds. (b) Image of a densified collagen construct before tube excision. Scale bar, 500 µm. (c) Maximum-intensity projection image 
depicting a tube populated with GFP+ ECOs after its generation. Scale bar, 30 µm. (d) Confocal microscopy image showing the lumen patency of 
an ECO-populated collagen tube. Scale bar, 30 µm. (e) Bright-field (left) and fluorescence (right) images of a tube in which GFP+ ECOs are nearly 
confluent. Scale bars, 100 µm. (f) IF analyses demonstrating the expression of biliary markers by ECOs following the generation of an ECO-populated 
tube. Scale bar, 100 µm. (g) qRT–PCR analyses demonstrating the expression of biliary markers by ECOs before (ECOs) and after (scaffold) the 
generation of ECO-populated collagen tubes. Embryonic stem cells were used as a negative control. n = 4 ECO lines; n = 4 ES lines. Center line, 
median; box, IQR; whiskers, range (minimum to maximum). Values are given relative to HMBS expression. (h,i) ECO-populated tubes exhibit ALP (h) 
and GGT (i) activity. Scale bars in h, 500 µm. MEFs, mouse feeder cells used as a negative control; scaffold, ECO-populated densified collagen tubes. 
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densified collagen tube. A midportion of the native CBD was removed, 
and an ECO-populated collagen tube was anastomosed end to end 
to the proximal and distal duct remnants (Fig. 6a). Fibroblast-popu-
lated tubes were used as a negative control. Biliary reconstruction 
was achieved in all animals transplanted with ECO-populated tubes 
(Fig. 6b,c and Supplementary Fig. 13a–d), with mice followed up 
for up to 1 month post-transplantation (Supplementary Fig. 13d). 
Histology, IF and qRT–PCR analyses (Fig. 6d–f and Supplementary 
Fig. 13a,b) demonstrated a patent lumen, with the transplanted 
GFP+ cells forming biliary epithelium (Fig. 6e,f and Supplementary 
Fig. 13a,b), and confirmed the expression of biliary markers such 
as KRT19, KRT7, HNF-1β, CFTR and SOX9 by the engrafted 
cells (Fig. 6d,f and Supplementary Fig. 13b). These analyses also 
illustrated the presence of mouse stromal and endothelial cells 
(Supplementary Fig. 13b). Moreover, we observed minimal apop-
tosis and proliferation in the transplanted tubes 1 month after trans-
plantation, confirming the stability and integrity of the reconstituted 
biliary epithelium (Supplementary Fig. 13b,c). Lumen patency 
was further confirmed by FITC cholangiogram, MRCP and serum 
measurements of cholestasis markers (Fig. 6g, Supplementary 
Fig. 13e,f and Supplementary Video 3). Accordingly, animals receiv-
ing ECO-populated tubes exhibited no elevation in serum levels of 











































































































































Figure 6 Bile duct replacement using ECO-populated densified collagen tubes. (a) Schematic representation of the method used for bile duct 
replacement. (b) Post-mortem images of mice that received an ECO-populated collagen tube (ECOs) versus a fibroblast-populated tube (fibroblasts).  
Bile flow results in yellow pigmentation of the ECO-populated tube. The white color of the fibroblast-populated conduit together with the dilated, bile-
filled (yellow color) proximal bile duct (PBD) suggests luminal occlusion, resulting in bile leak (yellow peritoneal pigmentation, white dashed line).  
SC, collagen tubular scaffold; DBD, distal bile duct. Scale bars, 500 µm. (c) Images of a thin-walled construct resembling the native bile duct from a 
mouse receiving an ECO-populated tube versus a thickened construct with no distinguishable lumen from a mouse receiving a fibroblast-populated tube. 
Scale bars, 500 µm. (d) qRT–PCR analyses using human-specific primers confirming the expression of biliary markers by ECOs on the transplanted 
ECO-populated tubes (ECOs in vivo) as compared to cultured ECOs (ECOs in vitro) and mouse biliary tissue used as a negative control; n = 4 tubes. 
Center line, median; box, IQR; whiskers, range (minimum to maximum). Values are given relative to HMBS expression. (e) H&E staining demonstrating  
the presence of biliary epithelium and a patent lumen in an ECO-populated tube but not a fibroblast-populated construct. Scale bars, 100 µm.  
(f) IF analyses showing GFP+CK19+ epithelium lining the lumen of an ECO-populated construct versus obliteration of the lumen by fibroblasts in a 
fibroblast-populated construct. Scale bars, 100 µm. (g) FITC cholangiograms showing lumen patency in an ECO-populated tube versus occlusion of the 
lumen in a fibroblast-populated construct. Scale bars, 100 µm (ECOs) and 500 µm (fibroblasts). (h) ALP activity is observed only in ECO-populated 










































A r t i c l e s
962	 VOLUME 23 | NUMBER 8 | AUGUST 2017 nAture medicine
cholestasis markers (bilirubin and ALP; Supplementary Fig. 13e) 
and showed a patent lumen on imaging (Fig. 6g and Supplementary 
Fig. 13f), whereas bioartificial CBDs retained their ALP activity 
in vivo (Fig. 6h).
In contrast, all fibroblast-populated collagen tubes failed because of 
lumen occlusion (Fig. 6b,c,e–g and Supplementary Fig. 13d), result-
ing in high biliary pressures and bile leak through the site of anasto-
mosis (Fig. 6b). In conclusion, our results demonstrate the capacity of 
ECO-populated collagen tubes to replace the native CBD in vivo.
DISCUSSION
We have demonstrated that epithelial cells from the extrahepatic biliary 
tree can be expanded and propagated in vitro while maintaining their 
cholangiocyte transcriptional signature and functional characteristics. 
In addition, our results show that primary cholangiocytes expanded 
in vitro as organoids have a unique potential in organ regeneration. 
Indeed, to our knowledge, our system provides the first proof of prin-
ciple for the application of regenerative medicine in the context of CBD 
pathology. The capacity to replace a diseased CBD with an in vitro–bio-
engineered ECO-populated tube could have a considerable impact on 
the management of disorders such as biliary atresia, which constitutes 
the leading cause for pediatric liver transplantation1, or ischemic stric-
tures, which is one of the most common complications following trans-
plantation3. Consequently, ECO-populated scaffolds represent a new 
system with high clinical relevance in the field of cholangiopathies.
Studies of the extrahepatic biliary epithelium have been limited 
by technical challenges in the long-term culture and large-scale 
expansion of primary cholangiocytes. These challenges have so 
far precluded large-scale experiments, such as transcriptomic and 
genome-wide analyses, which are urgently needed to better under-
stand diseases of the bile duct such as PSC and cholangiocarcinoma. 
The capacity of ECOs for large-scale expansion could address this 
need. Indeed, we demonstrate that, starting from 105 extrahepatic 
cholangiocytes, we can generate from 1020–1025 cells after 20 passages 
in culture. Therefore, ECOs not only represent a new source of cells 
for cell-based therapy but also provide a unique model system for 
studying the physiology and modeling disorders of the extrahepatic 
biliary tree in vitro.
Access to human tissue represents a considerable limitation for 
systems based on primary cells. However, we show that ECOs can 
be obtained not only from the CBD but also from the gallbladder. 
Gallbladder tissue is easily accessible and is routinely discarded follow-
ing liver transplantation and cholecystectomy, one of the most common 
surgical procedures performed. Furthermore, in individuals not under-
going surgery, the CBD can be accessed using minimally invasive pro-
cedures such as ERCP, and we demonstrate that cholangiocytes can be 
obtained through brushings, which are routinely performed to acquire 
histology specimens. Notably, no morphological or functional differ-
ences were observed between organoids obtained with these different 
methods. Moreover, because of the scalability of our system, only a 
small amount of starting material is required. Finally, recent progress in 
replacing Matrigel with custom-made hydrogels to grow gut organoids25 
suggests that translating our system from Matrigel to a more clinically 
relevant good manufacturing practice (GMP)-compatible matrix could 
be feasible. When considered together, these approaches effectively 
address the challenges of tissue availability and create the possibility of 
cell-based therapy with autologous as well as allogeneic cells.
Notably, the derivation of primary hepatic stem cells using an orga-
noid culture system has been reported previously12. However, the capac-
ity of the resulting cells to differentiate into functional cholangiocytes 
and populate the biliary tree in vivo remains to be demonstrated. 
Furthermore, in vivo applications of such platforms could be restricted 
by contamination with stem cells that have a capacity to proliferate 
inappropriately after transplantation and/or differentiate into non-
biliary cell types. Despite the association between organoids and 
adult stem cells26, we never observed the expression of hepatocyte 
or pancreatic markers during our experiments, either in vitro or 
after transplantation, suggesting that the differentiation capacity of 
ECOs is limited to that of their lineage of origin. Moreover, canonical 
Wnt signaling, which is crucial for the expansion of adult stem cell 
organoids27, is blocked in our culture conditions through the use of 
DKK-1; further studies may be required to fully elucidate the role 
of R-spondin in our system. Considered together, these observations 
suggest that our culture system does not include a stem cell popula-
tion. However, we cannot completely exclude the possibility that these 
cells could represent a biliary progenitor cell population, on the basis 
of their ability to self-propagate and generate organoids from single 
cells (Supplementary Video 4).
Of note, we have recently established a system for the generation of 
cholangiocyte-like cells (CLCs) from human pluripotent stem cells9. 
However, it is worth noting that there are considerable differences 
between ECOs and CLCs. CLCs correspond to intrahepatic cholan-
giocytes, whereas ECOs represent the extrahepatic biliary epithelium. 
These two cell types are distinct in terms of embryological origin and 
disease involvement14, and the two systems therefore complement each 
other for studies of the biliary tree. Indeed, CLCs are generated follow-
ing a natural path of development and maintain fetal characteristics. 
Therefore, they provide a unique system for studies of human biliary 
development and developmental diseases, which are not possible using 
adult cells. However, CLCs may require a period of adjustment and 
further maturation in vivo, whereas mature, functional cells, such 
as ECOs, are required for coping with biliary injury in the acute set-
ting and may be better suited for regenerative medicine applications. 
Furthermore, although human induced pluripotent stem cells represent 
a very good source of cells capable of generating almost any tissue, the 
initial derivation and characterization of these cell lines remains time-
consuming and variability in differentiation capacity is still a challenge. 
ECOs can be derived in less than 24 h with very high efficiency and can 
be expanded through multiple passages without losing their original 
characteristics. Consequently, ECOs and CLCs are comparable in terms 
of scalability and are complementary in terms of applications, with the 
mature phenotype of ECOs providing a unique advantage for regenera-
tive medicine applications in the context of tissue repair.
In conclusion, our results open up new avenues for the use of extra-
hepatic primary biliary tissue as a novel platform for in vitro studies, 
disease modeling and cell-based therapy applications.
METHODS
Methods, including statements of data availability and any associated 
accession codes and references, are available in the online version of 
the paper.
Note: Any Supplementary Information and Source Data files are available in the 
online version of the paper.
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Primary biliary tissue. Primary biliary tissue (bile duct or gallbladder) was 
obtained from deceased organ donors from whom organs were being retrieved 
for transplantation. The gallbladder or a section of the bile duct was excised 
during the organ retrieval operation after obtaining informed consent from 
the donor’s family (REC reference numbers: 12/EE/0253, NRES Committee 
East of England, Cambridge Central and 15/EE/0152 NRES Committee East 
of England, Cambridge South).
Isolation of primary cholangiocytes. Excised bile duct segments were placed in a 
10-cm plate and washed once with William’s E medium (Gibco, Life Technologies). 
A longitudinal incision was made along the wall of the excised bile duct segment, 
exposing the lumen, and 10–15 ml of William’s E medium was added to cover 
the tissue. The luminal epithelium was subsequently scraped off using a surgical 
blade while the tissue was submerged in medium. The supernatant was collected, 
and the tissue and plate were washed two or three times with William’s E medium 
to collect any remaining cells. The supernatant and washes were combined and 
centrifuged at 444g for 4 min. The pellet was washed with William’s E medium 
and recentrifuged; the supernatant was discarded (Fig. 1a).
Excised gallbladders were placed in a 15-cm plate, a longitudinal incision 
was made along the wall of the excised gallbladder and the lumen was washed 
once with William’s E medium (Gibco, Life Technologies). Cholangiocytes were 
isolated following the method described above (Supplementary Fig. 2a).
For cholangiocyte isolation through brushing, an excised bile duct segment 
was placed in a 10-cm plate and cannulated using an ERCP brush. The luminal 
surface was brushed 10–20 times, and the cells were collected by washing the 
brush several times in a Falcon tube containing 40–50 ml of William’s E medium 
(Supplementary Fig. 2b).
Generation and culture of ECOs. Isolated primary cholangiocytes were cen-
trifuged at 444g for 4 min and resuspended in a mixture of 66% Matrigel (BD 
Biosciences, 356237) and 33% William’s E medium (Gibco, Life Technologies) 
supplemented with 10 mM nicotinamide (Sigma-Aldrich), 17 mM sodium 
bicarbonate (Sigma-Aldrich), 0.2 mM 2-phospho-l-ascorbic acid trisodium 
salt (Sigma-Aldrich), 6.3 mM sodium pyruvate (Invitrogen), 14 mM glucose 
(Sigma-Aldrich), 20 mM HEPES (Invitrogen), ITS + premix (BD Biosciences), 
0.1 µM dexamethasone (R&D Systems), 2 mM Glutamax (Invitrogen), 100 U/ml 
penicillin and 100 µg/ml streptomycin, 20 ng/ml EGF (R&D Systems), 500 ng/ml 
R-spondin (R&D Systems) and 100 ng/ml DKK-1 (R&D Systems). The cell sus-
pension was plated in a 24-well plate format at 50 µl/well so that a small dome 
of Matrigel formed in the center of each well, and plates were then incubated at 
37 °C for 10–30 min until the Matrigel solidified. Subsequently, 1 ml of William’s 
E medium with supplements was added to each well. The culture medium was 
changed every 48 h.
To split the cells, Matrigel was digested by adding Cell Recovery Solution 
(Corning) for 30 min at 4 °C. The resulting cell suspension was collected, 
centrifuged at 444g for 4 min, washed once with William’s E medium and 
resuspended in 66% Matrigel and 33% William’s E medium with supplements, 
as described above.
All experiments were performed using passage 20 ECOs unless 
otherwise stated.
Cell line identity. Demographic data for the donor corresponding to each ECO 
line are provided in Supplementary Table 1. Following derivation, ECO lines 
were authenticated by matching their karyotype (Supplementary Fig. 4b) to 
the sex of the donor. The lines were tested on a regular basis and found to be 
negative for mycoplasma contamination.
Immunofluorescence, RNA extraction and qRT–PCR. IF analysis, RNA extrac-
tion and qRT–PCR were performed as previously described9. A complete list of the 
primary and secondary antibodies used is provided in Supplementary Table 3. 
A complete list of the primers used is provided in Supplementary Table 4.
All qRT–PCR data are presented as the median, interquartile range (IQR) and 
range (minimum to maximum) of four independent ECO lines unless otherwise 
stated. Values are given relative to that of the housekeeping gene hydroxymeth-
ylbilane synthase (HMBS).
All IF images were acquired using a Zeiss Axiovert 200M inverted 
microscope or a Zeiss LSM 700 confocal microscope. ImageJ 1.48k 
software (Wayne Rasband, NIH; http://imagej.nih.gov/ij) was used for image 
processing. IF images are representative of three different experiments. 
IF images of reconstructed gallbladder sections are representative of five 
different animals.
Microarrays. RNA was assessed for concentration and quality using a SpectroStar 
(BMG Labtech) and a Bioanalyzer (Agilent Technologies). Microarray experi-
ments were performed at Cambridge Genomic Services, University of Cambridge, 
UK, using the HumanHT-12 v4 Expression BeadChip (Illumina) according 
to the manufacturer’s instructions. Briefly, 200 ng of total RNA underwent 
linear amplification using the Illumina TotalPrep RNA Amplification Kit 
(Life Technologies) following the manufacturer’s instructions. The concentra-
tion, purity and integrity of the resulting cDNA were measured by SpectroStar 
and Bioanalyzer. Finally, cDNA was hybridized to the HumanHT-12 v4 
BeadChip overnight, and the arrays were subsequently washed, stained and 
scanned using the Bead Array Reader (Illumina). The RNA used for microarray 
analysis was collected from three different ECO lines (n = 3). Microarray experiments 
were performed at Cambridge Genomic Services, University of Cambridge, UK, 
using the HumanHT-12 v4 Expression BeadChip (Illumina) according to the 
manufacturer’s instructions.
Microarray analysis. Raw data were loaded into R using the lumi package from 
Bioconductor28 and divided into subsets according to the groups being com-
pared; only the samples involved in a given comparison were used. Subsets were 
then filtered to remove any nonexpressed probes using the detection P value 
from Illumina. Across all samples, probes for which the intensity value was not 
statistically significantly different (P > 0.01) from those of the negative controls 
were removed from the analysis. Following filtering, the data were transformed 
using Variance Stabilization Transformation29 from lumi and then normalized 
to remove technical variation between arrays using quantile normalization. 
Comparisons were performed using the limma package30, with results corrected 
for multiple testing using false discovery rate (FDR) correction. Finally, the 
quality of the data was assessed, along with the correlations between samples 
within groups.
Probes differentially expressed between hepatocytes and ECOs representing 
the aggregate transcriptional ‘signature’ of ECOs were selected for Euclidean 
hierarchical clustering using Perseus software (MaxQuant). Standard scores 
(z-scores) were calculated for the log2-normalized probe expression val-
ues across the different conditions and used for this analysis. Heat maps and 
principal-component analysis (PCA) plots were generated using MaxQuant 
Perseus software (http://www.perseus-framework.org/)31. Functional annota-
tion and GO analyses were performed on genes that were differentially expressed 
between primary cholangiocytes and ECOs (Fig. 1d) using the NIAID/NIH 
Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.8 
(https://david.ncifcrf.gov/)32,33.
Western blot analysis. Total protein was extracted with lysis buffer (50 mM 
Tris pH 8, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton 
X-100, and protease and phosphatase inhibitors). Protein concentrations 
were determined using the BCA Protein Assay Kit (Thermo Fisher Scientific) 
according to the manufacturer’s instructions. Samples were prepared for 
western blot analysis by adding 1× NuPAGE LDS Sample Buffer with 1% β-
mercaptoethanol and were incubated for 5 min at 95 °C. Protein (25 µg) was 
separated by 4–12% NuPAGE Bis-Tris protein gel (Invitrogen) and transferred 
onto polyvinylidene difluoride (PVDF) membrane (Bio-Rad). Proteins were 
detected by probing with antibodies specific to phospho-β-catenin (Ser33/
Ser37/Thr41) (Cell Signaling Technology, 9561), active β-catenin (Millipore, 
05-665), total β-catenin (R&D, AF1329) and β-tubulin (Sigma, T4026), 
which was followed by incubation with horseradish-peroxidase-conjugated 
anti-mouse, anti-goat or anti-rabbit secondary antibodies. Membranes were 
developed using Pierce ECL western blotting substrate (Thermo Scientific) 
according to the manufacturer’s instructions. The raw western blot images are 
provided in Supplementary Figure 14. Validation information for each of these 












































Rho kinase activity analyses. Rho kinase activity was measured using a 
commercially available kit (Cell Biolabs, STA-416) according to the manufac-
turer’s instructions.
Flow cytometry analyses. ECOs were collected using Cell Recovery Solution 
(Corning) for 30 min at 4 °C and were then centrifuged at 444g for 4 min and 
dissociated to single cells using TrypLE Express (Gibco). Cells were subsequently 
fixed using 4% paraformaldehyde (PFA) for 20 min at 4 °C. Cell staining and 
flow cytometry analyses were performed as previously described9,34.
Karyotyping. ECOs were collected using Cell Recovery Solution (Corning), 
dissociated to single cells as described above, plated in gelatin-coated plates and 
cultured using William’s E medium with supplements. When cells were subcon-
fluent, usually after 72 h, the cultures were incubated for 3–4 h with William’s E 
medium with supplements containing 0.1 µg/ml colcemid (Karyomax, Gibco). 
Cells were then collected using trypsin-EDTA (0.05%) (Gibco) for 4–5 min at 
37 °C, centrifuged at 344g for 5 min and resuspended in 5 ml of KCl hypotonic 
solution (0.055 M). The suspension was recentrifuged at 344g for 5 min, 2 ml 
of a 3:1 100% methanol:glacial acetic acid solution was added and slides were 
prepared as previously described35.
Comparative genomic hybridization analyses. Genomic DNA was labeled 
using the BioPrime DNA Labeling Kit (Invitrogen) according to the manu-
facturer’s instructions, and samples were hybridized to Agilent Sureprint G3 
unrestricted CGH ISCA 8×60K human genome arrays following the manufac-
turer’s protocol, as previously described36. The data were analyzed using Agilent 
CytoGenomics Software.
Rhodamine 123 transport assay. Rhodamine 123 transport assays were per-
formed as previously described9, and images were acquired using a Zeiss LSM 
700 confocal microscope. Fluorescence intensity was measured between the 
organoid interior and exterior, and luminal fluorescence was normalized to the 
background level for the extraluminal space. Each experiment was performed 
in triplicate. Error bars represent s.d.
Cholyl-lysyl-fluorescein transport assay. To achieve loading with CLF 
(Corning), ECOs were split in 5 µM CLF and incubated at 37 °C for 30 min. 
Images were acquired using a Zeiss LSM 700 confocal microscope, and 
fluorescence intensity was measured between the organoid interior and exte-
rior as described for the rhodamine 123 transport assay. To demonstrate that 
the observed changes in CLF fluorescence intensity were secondary to active 
export of CLF from the organoid lumen, the experiment was repeated with 5 µM 
unconjugated FITC (Sigma-Aldrich) as a control. Fluorescence intensity meas-
urement was performed as described for the rhodamine 123 transport assay. 
Each experiment was performed in triplicate. Error bars represent s.d.
g-glutamyl transferase activity. GGT activity was measured in triplicate using 
the MaxDiscovery GGT Enzymatic Assay Kit (Bioo Scientific) based on the 
manufacturer’s instructions. Error bars represent s.d. Absorbance units refer to 
light absorbance at a wavelength of 405 nm.
Alkaline phosphatase staining. ALP staining was carried out using the BCIP/
NBT color development substrate (5-bromo-4-chloro-3-indolyl-phosphate/nitro 
blue tetrazolium) (Promega) according to the manufacturer’s instructions.
Responses to secretin and somatostatin. Responses to secretin and somatosta-
tin were assessed as previously described9.
Generation of ECOs expressing GFP. EGFP-expressing VSV-G pseudotyped 
recombinant HIV-1 lentiviral particles were produced with an optimized sec-
ond-generation packaging system by transient cotransfection of three plas-
mids into HEK-293T cells (ATCC, CRL-11268). EGFP expression is under 
the control of a core EF-1α promoter. All plasmids were a gift from D. Trono 
and obtained from Addgene (pWPT-GFP, 12255; psPAX2, 12260; pMD2.G, 
12259). Viral infection of organoids was performed as previously described37. 
Infected ECOs were expanded for two passages, collected as described above 
for flow cytometry analyses and cell sorted by flow cytometry for GFP+ cells. 
GFP-expressing single cells were plated using our standard plating method and 
cultured in William’s E medium with supplements for 1–2 weeks until fully 
grown ECOs developed.
Generation of ECO-populated PGA scaffolds. One-millimeter-thick PGA 
scaffolds with a PGA density of 50 mg/cm3 were used for all experiments. 
Prior to cell seeding, the PGA scaffolds were pretreated with 1 M NaOH 
for 10–30 s, washed three times, decontaminated in a 70% ethanol solution 
for 30 min and then air-dried for another 30 min until all of the ethanol had 
fully evaporated. All scaffolds were a gift from S. Sinha and obtained from 
Biomedical Structures (Biofelt).
ECOs were collected and dissociated into single cells as previously described 
for flow cytometry analyses; 5–10 × 106 cells were resuspended in 100 µl of 
William’s E medium with supplements and seeded on a scaffold surface area 
of 1 cm2. Scaffolds were incubated at 37 °C for 30–60 min to allow the cells to 
attach. The scaffolds were placed in the wells of a 24-well plate and checked at 
regular intervals during this period to ensure that the medium did not evaporate. 
If necessary, 10–20 µl of William’s E medium with supplements was added. After 
1 h, 2–3 ml of William’s E medium with supplements was added to the wells, and 
the medium was subsequently changed twice weekly.
Generation of densified collagen tubes. Densified collagen tubes were prepared 
using a novel approach. A 3D printed chamber was fabricated, consisting of a 
funnel piece and a base plate. A 250-µm-thick metallic wire was mounted into 
the base plate and fed through the center of the funnel. Absorbent paper towels 
were compacted between the two 3D printed parts, which were then screwed 
together. Collagen gel solution (5 mg/ml), loaded with cells, was poured into 
the funnel and gelled at 37 °C for 30 min. The screws were then loosened, and 
water was drawn out of the collagen gel by placing the 3D printed chambers at 
37 °C for 2–4 h. A cell-loaded densified collagen tube was thus formed with a 
250-µm lumen and a wall thickness of 30–100 µm, determined by the duration 
of the drying phase. Upon removal from the chamber, the tube was trimmed for 
excess collagen and cut to the required length.
Culture of HMECs. HMECs and the required tissue culture consumables 
were purchased as a kit from Lonza (CC-2551B), and the cells were cultured 
according to the supplier’s instructions. The cells were tested for mycoplasma 
by the manufacturer.
Animal experiments. All animal experiments were performed in accordance 
with UK Home Office regulations (UK Home Office Project License numbers 
PPL 80/2638 and PPL 70/8702). Immunodeficient NSG mice, which lack B, 
T and NK lymphocytes38, were bred in house, and food and water were avail-
able ad libitum before and after procedures. A mix of male and female animals 
aged approximately 6–8 weeks was used. All of the ECO constructs used were 
populated with ECOs derived from human CBD.
Generation of the extrahepatic biliary injury mouse model. To generate a 
model of EHBI, midline laparotomy was performed and the gallbladder was 
mobilized by dividing the ligamentous attachment connecting its fundus to the 
anterior abdominal wall under isoflurane general anesthesia. A longitudinal 
incision was then made along two-thirds of the length of the gallbladder, from 
the fundus toward Hartmann’s pouch (the neck of the gallbladder).
Biliary reconstruction in EHBI mice. To reconstruct the gallbladder, a scaffold 
section measuring approximately 1 × 1 mm2 (seeded with ECOs or lacking ECOs 
in controls) was sutured as a ‘patch’ to close the defect using 4–6 interrupted 
10-0 nonabsorbable nylon sutures under 40× magnification. The laparotomy 
was closed in two layers with continuous 5-0 absorbable Vicryl sutures. The 
animals were given buprenorphine (temgesic; 0.1 mg/kg) analgesia as a bolus 
and observed every 15 min in individual cages until fully recovered.
Eight animals underwent biliary reconstruction using an ECO-populated 
scaffold. All these animals survived to 104 d after surgery without complications 
and were culled electively for further analyses. Two control experiments were 












































scaffolds. Both animals died within 24 h from bile leak; therefore, no further 
control experiments were performed to minimize animal discomfort.
Bile duct replacement. The native CBD was divided, and a short segment was 
excised. The populated densified collagen tube was anastomosed end to end, 
using interrupted 10-0 nylon sutures, between the divided proximal and distal 
CBD segments. A length of 5-0 nylon suture material (diameter, 100 µm) was 
inserted into the collagen tube and fed into the proximal and distal CBD seg-
ments to ensure patency of the lumen during anastomosis. After anastomosis 
was complete, the 5-0 suture was pushed into the duodenum through the distal 
bile duct and was removed through an incision in the duodenum, which was 
then closed with interrupted 10-0 nylon sutures. Lumen patency was assessed 
at the time of transplantation through light microscopy and cannulation of the 
lumen with a 5-0 nonabsorbable suture. Transplantation was abandoned as futile 
in the case of fully occluded tubes due to cell infiltration. These events were 
considered to represent construct failure rather than surgical complications and 
were therefore not censored in the survival analysis.
Bile duct ligation. C57BL/6 mice were purchased from The Jackson Laboratory. 
Mice were housed and bred in a Minimal Disease Unit at the animal facility at 
Oslo University Hospital, Rikshospitalet, Oslo, Norway. All experiments were 
performed on male mice aged 8–12 weeks. Median laparotomy was performed, 
and the CBD was exposed and ligated close to the junction of the hepatic bile 
ducts. Sham-operated mice underwent the same procedure without ligation. 
Serum was collected after 5 d. Alanine transaminase (ALT), aspartate transami-
nase (AST) and ALP levels were measured in serum using an ADVIA 1800 
instrument (Siemens) at the Central Laboratory, Norwegian School of Veterinary 
Science. All animal experiments were approved by the Norwegian Food Safety 
Authority (project license no. FOTS 8210/15), and all animals received humane 
care in line with the NIH Guide for the Care and Use of Laboratory Animals.
Blood sample collection. Blood was taken using a 23-gauge needle 
directly from the inferior vena cava under terminal anesthesia at the time the 
animals were electively culled and transferred into 1.5-ml Eppendorf tubes for 
further processing.
Blood sample processing. Blood samples were routinely processed by 
the University of Cambridge Core Biochemical Assay Laboratory (CBAL). 
All sample analysis was performed on a Siemens Dimension EXL analyzer 
using reagents and assay protocols supplied by Siemens.
Light microscopy imaging. Light microscopy images of excised reconstructed 
gallbladders were acquired using a Leica MZFLIII fluorescence dissecting 
microscope. The images are representative of five animals.
Cryosectioning and histology. Excised gallbladders were fixed in 4% PFA, 
immersed in sucrose solution overnight, mounted in optimal cutting tempera-
ture (OCT) compound and stored at −80 °C until sectioning. Sections were cut 
to a thickness of 10 µm using a cryostat microtome and mounted on microscopy 
slides for further analysis.
H&E staining. H&E staining was performed using Sigma-Aldrich reagents 
according to the manufacturer’s instructions. Briefly, tissue sections were 
hydrated, treated with Meyer’s hematoxylin solution for 5 min (Sigma-Aldrich), 
washed with warm tap water for 15 min, placed in distilled water for 30–60 s 
and incubated with eosin solution (Sigma-Aldrich) for 30–60 s. Sections were 
subsequently dehydrated and mounted using Eukitt quick-hardening mounting 
medium (Sigma-Aldrich). Histology sections were reviewed by an independent 
histopathologist with a special interest in hepatobiliary histology (S.D.).
TUNEL assay. TUNEL assays were performed using a commercially available 
kit (Abcam, ab66110) according to the manufacturer’s instructions.
FITC cholangiography. In situ FITC cholangiography was performed in 
euthanized animals after dissection of the gallbladder from adherent liver 
lobes but before surgical interruption of the extrahepatic biliary tree. The 
distal bile duct was cannulated with a 23½-gauge needle, FITC was 
injected in retrograde into the gallbladder and images were taken under a fluo-
rescent microscope.
Magnetic resonance cholangiopancreatography. MRCP was performed 
after euthanization of the animals and was carried out at 4.7 T using a Bruker 
BioSpec 47/40 system. A sequence with rapid acquisition followed by relaxation 
enhancement was used with an echo train length of 40 echoes at 9.5-ms intervals, 
a repetition time of 1,000 ms and a field of view of 5.84 × 4.18 × 4.18 cm3 with 
a matrix of 256 × 180 × 180 pixels, yielding an isotropic resolution of 230 µm. 
The actively decoupled four-channel mouse cardiac array provided by Bruker 
was used for imaging.
For the second mouse imaged, a 2D sequence was used with slightly 
varied parameters (24 echoes spaced at 11-ms intervals to give an effective 
echo time of 110 ms, repetition time of 5,741 ms, matrix size of 256 × 256, 
field of view of 4.33 × 5.35 cm2; yielding a planar resolution of 170 × 200 µm2) 
for a higher signal-to-noise ratio to improve visualization of the biliary ducts. 
Fifteen 0.6-mm slices were acquired coronally through the liver and gallbladder. 
For acquisition, a volume coil was used to reduce the impact of radiofrequency 
inhomogeneity.
The biliary duct and gallbladder images were prepared by maximum-intensity 
projection. Structural imaging to rule out neoplastic growth was performed 
using a T1-weighted 3D FLASH (fast low-angle shot) sequence with a flip angle 
of 25°, a repetition time of 14 ms and an echo time of 7 ms. The matrix was 
512 × 256 × 256 with a field of view of 5.12 × 2.56 × 2.56 cm3, for a final isotropic 
resolution of 100 µm.
The MRCP images were reviewed by two independent radiologists with 
a special interest in hepatobiliary radiology (E.M.G. and S.U.).
Statistical analyses. All statistical analyses were performed using GraphPad 
Prism 6. For small sample sizes, where descriptive statistics were not appropri-
ate, individual data points were plotted. For comparison of two mean values, 
a two-sided Student’s t-test was used to calculate statistical significance. Normal 
distribution of our values was confirmed using the D’Agostino–Pearson omnibus 
normality test where appropriate. Variance between samples was tested using 
the Brown–Forsythe test. To compare multiple groups to a reference group, one-
way ANOVA with Dunnett’s correction for multiple comparisons was used for 
groups with equal variance and the Kruskal–Wallis test with Dunn’s correction 
for multiple comparisons was applied for groups with unequal variance. Survival 
was compared using log-rank (Mantel–Cox) tests. Where given, the number 
of replicates (n) refers to the number of ECO lines or the number of different 
animals, unless otherwise stated. Further details of the statistical analyses per-
formed are provided in Supplementary Table 5.
For animal experiments, group sizes were estimated on the basis of previous 
study variance. Final animal group sizes were chosen to allow elective culling 
at different time points while maintaining n > 4 animals surviving past 30 d to 
ensure reproducibility. No statistical methods were used to calculate sample 
size. No formal randomization method was used to assign animals to study 
groups. However, littermate animals from a given cage were randomly assigned 
to experimental or control groups by a technician not involved in the study. No 
animals were excluded from the analysis. No blinding was used when only one 
group of animals survived for radiology imaging. In cases where more than one 
group survived to be imaged, such as when gallbladders were reconstructed with 
fibroblasts versus ECOs, both radiologists reviewing the images (E.G. and S.U.) 
where blinded to the method of reconstruction.
Data availability. The microarray data are open access and available online on 
ArrayExpress under accession code E-MTAB-4591.
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